202 related articles for article (PubMed ID: 12819906)
1. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study.
Bos G; Dekker JM; Nijpels G; de Vegt F; Diamant M; Stehouwer CD; Bouter LM; Heine RJ;
Diabetologia; 2003 Jul; 46(7):910-6. PubMed ID: 12819906
[TBL] [Abstract][Full Text] [Related]
2. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
Liu J; Joshi D; Sempos CT
Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
[TBL] [Abstract][Full Text] [Related]
3. The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk.
Retnakaran R; Qi Y; Connelly PW; Sermer M; Hanley AJ; Zinman B
J Clin Endocrinol Metab; 2010 Sep; 95(9):4345-53. PubMed ID: 20631030
[TBL] [Abstract][Full Text] [Related]
4. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.
Pascot A; Després JP; Lemieux I; Alméras N; Bergeron J; Nadeau A; Prud'homme D; Tremblay A; Lemieux S
Diabetes Care; 2001 May; 24(5):902-8. PubMed ID: 11347752
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study.
Braun B; Zimmermann MB; Kretchmer N; Spargo RM; Smith RM; Gracey M
Diabetes Care; 1996 May; 19(5):472-9. PubMed ID: 8732712
[TBL] [Abstract][Full Text] [Related]
6. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
8. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
[TBL] [Abstract][Full Text] [Related]
9. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
[TBL] [Abstract][Full Text] [Related]
10. Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance.
Pascot A; Després JP; Lemieux I; Bergeron J; Nadeau A; Prud'homme D; Tremblay A; Lemieux S
Diabetologia; 2000 Sep; 43(9):1126-35. PubMed ID: 11043858
[TBL] [Abstract][Full Text] [Related]
11. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
Yang YD; Zhai GR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
[TBL] [Abstract][Full Text] [Related]
12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
13. Plasma triglyceride level and mortality from coronary heart disease.
Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
[TBL] [Abstract][Full Text] [Related]
14. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
Snijder MB; Heine RJ; Seidell JC; Bouter LM; Stehouwer CD; Nijpels G; Funahashi T; Matsuzawa Y; Shimomura I; Dekker JM
Diabetes Care; 2006 Nov; 29(11):2498-503. PubMed ID: 17065691
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men.
Wang J; Stančáková A; Soininen P; Kangas AJ; Paananen J; Kuusisto J; Ala-Korpela M; Laakso M
J Intern Med; 2012 Dec; 272(6):562-72. PubMed ID: 22650159
[TBL] [Abstract][Full Text] [Related]
17. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
18. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
Hadaegh F; Harati H; Ghanbarian A; Azizi F
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
[TBL] [Abstract][Full Text] [Related]
19. Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk.
Bertsch RA; Merchant MA
Perm J; 2015; 19(4):4-10. PubMed ID: 26517432
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
